EUVIMEDEUVIMED entdecken
Open Access

Magnesium bioresorbable scaffold (Magmaris) versus polymer biodegradable ultrathin drug-eluting stent (Ultimaster) in acute coronary syndrome. Mid-term outcomes (2 years)

Adrian Włodarczak, Piotr Rola, Szymon Włodarczak, Marek Szudrowicz, Joanna Jaroszewska-Pozorska, Mateusz Barycki, Łukasz Furtan, Michalina Kędzierska, Adrian Doroszko, Maciej Lesiak

Advances in Interventional Cardiology · 2024 · 20 (1) · 67-75

DOI: 10.5114/aic.2024.136901 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advances in Interventional Cardiology, 2024. Verfasst von Adrian Włodarczak und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, The Copper Health Centre (MCZ), Lubin, Poland. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Acute coronary syndrome (ACS) is a well-known risk factor for adverse clinical outcomes in percutaneous coronary intervention (PCI). Therefore, evaluation of coronary stents in this challenging clinical scenario can provide unique information on device safety and efficacy. Bioresorbable scaffolds (BRS) were designed to overcome long-term complications related to permanent vessel caging with a permanent metallic drug-eluting stent (DES).

Aim

We designed this study to evaluate the mid-term safety and efficiency of the Magmaris BRS in comparison to the leading new-generation ultrathin DES Ultimaster in the ACS population. Material and methods: We present a retrospective analysis of 2-year follow-up data. The primary outcomes consisted of death from cardiac causes, myocardial infarction, and in-stent thrombosis. The second main study endpoint was defined as target-lesion failure (TLF).

Results

The study population consisted of two cohorts, the first of 193 patients treated with Magmaris implantation and the second of 169 patients treated with Ultimaster implantation. At the 2-year follow-up, there were no significant differences in both study cohorts in terms of primary outcome (5.1% vs. 11%; p = 0.051), and TLF (5.6% vs. 8%, p = 0.41).

Conclusions

Treatment with a second-generation BRS (Magmaris) versus a novel second-generation DES (Ultimaster) in non-ST-elevation acute coronary syndrome (NSTE-ACS) was associated with similar rates of target lesion failure at 2-year follow-up.

Schlagwörter

Stichwörter der Autor:innen

MagmarisUltimasteracute coronary syndromebioresorbable scaffolddrug-eluting stentmagnesiummid-termpolymer biodegradable

Autor:innen und Institutionen

  • Department of Cardiology, The Copper Health Centre (MCZ), Lubin, Poland.
  • Department of Cardiology, Provincial Specialized Hospital Legnica, Legnica, Poland.
  • Faculty of Medicine, Wroclaw Medical University, Wroclaw, Poland.
  • Department of Cardiology, Center for Heart Diseases, 4 Military Hospital, Faculty of Medicine, Wroclaw University of Science and Technology, Wroclaw, Poland.
  • 1 Department of Cardiology, University of Medical Sciences, Poznan, Poland.

Zitieren

APA

Włodarczak, A., Rola, P., Włodarczak, S., Szudrowicz, M., Jaroszewska-Pozorska, J., Barycki, M., Furtan, Ł., Kędzierska, M., Doroszko, A., & Lesiak, M. (2024). Magnesium bioresorbable scaffold (Magmaris) versus polymer biodegradable ultrathin drug-eluting stent (Ultimaster) in acute coronary syndrome. Mid-term outcomes (2 years). Advances in Interventional Cardiology, 20(1), 67-75. https://doi.org/10.5114/aic.2024.136901

Vancouver

Włodarczak A, Rola P, Włodarczak S, Szudrowicz M, Jaroszewska-Pozorska J, Barycki M, et al. Magnesium bioresorbable scaffold (Magmaris) versus polymer biodegradable ultrathin drug-eluting stent (Ultimaster) in acute coronary syndrome. Mid-term outcomes (2 years). Advances in Interventional Cardiology. 2024;20(1):67-75. doi:10.5114/aic.2024.136901

BibTeX
@article{Wodarczak2024,
  author = {Włodarczak, Adrian and Rola, Piotr and Włodarczak, Szymon and Szudrowicz, Marek and Jaroszewska-Pozorska, Joanna and Barycki, Mateusz and Furtan, Łukasz and Kędzierska, Michalina and Doroszko, Adrian and Lesiak, Maciej},
  title = {Magnesium bioresorbable scaffold (Magmaris) versus polymer biodegradable ultrathin drug-eluting stent (Ultimaster) in acute coronary syndrome. Mid-term outcomes (2 years)},
  journal = {Advances in Interventional Cardiology},
  year = {2024},
  volume = {20},
  number = {1},
  pages = {67--75},
  doi = {10.5114/aic.2024.136901}
}
Kostenlos starten →